Show simple item record

 
dc.contributorIDIAP Jordi Gol
dc.contributor.authorGómez-Sánchez, Leticia
dc.contributor.authorGarcía-Ortiz, Luis
dc.contributor.authorPatino-Alonso, Maria C.
dc.contributor.authorRecio-Rodríguez, José I.
dc.contributor.authorFeuerbach, Natalia
dc.contributor.authorRodríguez-Sánchez, Emiliano
dc.contributor.authorMaderuelo-Fernández, Jose A.
dc.contributor.authorRamos, Rafel
dc.contributor.authorGómez-Marcos, Manuel A.
dc.contributor.authorMARK Group
dc.contributor.authorMartí Lluch, Ruth
dc.contributor.authorAgudo-Conde, Cristina
dc.date.accessioned2018-02-06T10:47:23Z
dc.date.available2018-02-06T10:47:23Z
dc.date.issued2017-04-17
dc.identifier.citationGomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso MC, Recio-Rodriguez JI, Feuerbach N, Marti R, et al. Glycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study. PLoS One. 2017;12(4):e0175982.
dc.identifier.urihttps://hdl.handle.net/11351/3290
dc.descriptionBiomarkers; Blood Glucose; Arterial stiffness
dc.description.abstractBACKGROUND: Effect of prediabetes and normal glucose on arterial stiffness remains controversial. The primary aim of this study was to investigate the relationship of fasting plasma glucose (FPG), postprandial glucose (PG) and glycosylated haemoglobin (HbA1c) with brachial-ankle pulse wave velocity (baPWV) and cardio-ankle vascular index (CAVI) in Caucasian adults. The secondary aim was to analyse this relationship by glycaemic status. METHODS: Cross-sectional study. Setting: Primary care. Participants: 2,233 subjects, 35-74 years. Measures: FPG (mg/dL) and HbA1c (%) of all subjects were measured using standard automated enzymatic methods. PG (mg/dL) was self-measured at home two hours after meals (breakfast, lunch and dinner) for one day using an Accu-chek ® glucometer. CAVI was measured using a VaSera VS-1500® device (Fukuda Denshi), and baPWV was calculated using a validated equation. RESULTS: CAVI and baPWV values were significantly higher in subjects with diabetes mellitus than in glucose normal and prediabetes groups (p<0.001). FPG, PG and HbA1c were positively associated with CAVI and baPWV. The β regression coefficient for: HbA1c was 0.112 (CI 95% 0.068 to 0.155) with CAVI, 0.266 (CI 95% 0.172 to 0.359) with baPWV; for PG was 0.006 (CI 95% 0.004 to 0.009 and for FPG was 0.005 (CI 95% 0.002 to 0.008) with baPWV; and for PG was 0.002 (CI 95% 0.001 to 0.003) and 0.003 (CI 95% 0.002 to 0.004) with CAVI (p<0.01 in all cases). When analysing by hyperglycaemic status, FPG, PG and HbA1c were positively associated with CAVI and baPWV in subjects with type 2 diabetes mellitus. CONCLUSION: FPG, PG and HbA1c show a positive association with CAVI and baPWV, in Caucasian adults with intermediate cardiovascular risk factors. When analysing by hyperglycaemic status, the association is only maintained in subjects with type 2 diabetes mellitus. TRIAL REGISTRATION: Clinical Trials.gov Identifier: NCT01428934. Registered 2 September 2011. Retrospectively registered. Last updated September 8, 2016
dc.language.isoeng
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.sourceScientia
dc.subjectMarcadors bioquímics
dc.subjectGlucèmia
dc.subjectSang - Circulació
dc.subject.meshBiomarkers
dc.subject.meshBlood Glucose
dc.subject.meshPostprandial Period
dc.subject.meshVascular Stiffness
dc.subject.meshEuropean Continental Ancestry Group
dc.titleGlycemic markers and relation with arterial stiffness in Caucasian subjects of the MARK study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1371/journal.pone.0175982
dc.subject.decsbiomarcadores
dc.subject.decsglucosa sanguínea
dc.subject.decsperíodo posprandial
dc.subject.decsrigidez vascular
dc.subject.decsgrupo de ascendencia continental europea
dc.relation.publishversionhttp://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0175982&type=printable
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Gómez-Sánchez L] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. [García-Ortiz L] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. Biomedical and Diagnostic Sciences Department, University of Salamanca, Salamanca, Spain. [Patino-Alonso MC] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. Statistics Department, University of Salamanca, Salamanca, Spain. [Recio-Rodríguez JI] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. Department of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain. [Feuerbach N] San Agustín Health Center, Illes Balears Health Service (IBSALUT), Palma of Mallorca, Spain. [Martí R] Unitat of Suport the Recerca of Girona, Institut Universitari d’Investigació in Atenció Primària Jordi Gol (IDIAP Jordi Gol), Girona, Spain. Institut d’Investigació Biomèdica of Girona Dr. Josep Trueta (IDBGI), Girona, Spain. [Agudo-Conde C, Maderuelo-Fernández JA] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. [Rodríguez-Sánchez E, Gómez-Marcos MA] Primary Care Research Unit, the Alamedilla Health Center, Castilla and León, Health Service (SACyL) Salamanca, Spain. Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. Department of Medicine, University of Salamanca, Salamanca, Spain. [Ramos R] Unitat of Suport the Recerca of Girona, Institut Universitari d’Investigació in Atenció Primària Jordi Gol (IDIAP Jordi Gol), Girona, Spain. Institut d’Investigació Biomèdica of Girona Dr. Josep Trueta (IDBGI), Girona, Spain. Departament of Ciències Mèdiques, Facultat of Medicina, Universitat of Girona, Girona, Spain. [MARK Group] MARK Group, redIAPP: Research Network in Preventive Activities and Health Promotion, Girona, Spain
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record